 |
 |
|
|
|
RESÚMENES JUNIO 2010 |
Tratamiento de Otros Trastornos Neuropsiquiátricos
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3 - Slow-wave
sleep deficiency and enhancement: Implications for insomnia and its management
Derk-Jan Dijk
World
Journal of Biological Psychiatry. June 2010, Vol. 11, No. S1, Pages 22-28
3 - A prospective naturalistic multicentre study of
intravenous medications in behavioural emergencies: Haloperidol versus
flunitrazepam
Kotaro Hatta, Mitsuru
Nakamura, Kenichi Yoshida, Hiroshi Hamakawa, Toru Wakejima, Takao Nishimura, Ko
Furuta, Toshitaka Kawabata, Toyoaki Hirata, Chie Usui, Hiroyuki Nakamura and
Yutaka Sawa
Psychiatry Research. Volume 178, Issue 1, 30 June 2010, Pages 182-185
3 - Prophylactic
continuous administration of landiolol, a novel β1 blocker, blunts hyperdynamic responses during
electroconvulsive therapy without altering seizure activity
Zen’ichiro
Wajima
International
Journal of Psychiatry in Clinical Practice. June 2010, Vol. 14, No. 2, Pages 132-136
5 - Effect of Folic Acid, with or without Other B
Vitamins, on Cognitive Decline: Meta-Analysis of Randomized Trials
David S. Wald, Anuradhani
Kasturiratne and Mark Simmonds
The
American Journal of Medicine. Volume 123, Issue 6, June 2010, Pages 522-527.e2
3 - REM Sleep
Behaviour Disorder in Older Individuals: Epidemiology, Pathophysiology and
Management
Trotti, Lynn Marie
Drugs & Aging: 1 June 2010 - Volume 27 - Issue 6 -
pp 457-470
3! - Two-Year Outcome of Treatment With Central Stimulant Medication in
Adult Attention-Deficit/Hyperactivity Disorder: A Prospective Study
Susanne Bejerot, Eleonore M. Rydén, and
Christina M. Arlinde
3 - Biomarkers
as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type
Dementia: Implications for Trial Design
Ineke A. van Rossum, Stephanie Vos, Ron
Handels, Pieter Jelle Visser
Journal of Alzheimer's Disease. Volume 20, Number 3 /
2010: 881-891
3 - Can
Statins Prevent or Help Treat Alzheimer's Disease?
Bernadette McGuinness, Peter Passmore
Journal of Alzheimer's Disease. Volume 20, Number 3 /
2010:925-933
4 - Effects
of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer’s
Disease
Martin R.
Farlow, Jeffrey L. Cummings, Jason T. Olin, Xiangyi Meng
American Journal of Alzheimer's Disease and Other
Dementias, Vol. 25, No. 4, 347-352 (2010)
5 - A
randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with
placebo, in older subjects with age-associated memory impairment
Geoffrey
Dunbar, Ramana Kuchibhatla, and George Lee
Journal of Psychopharmacology June 11, 2010
3 - Who will be eligible? An investigation
of the dementia population eligible for cholinesterase treatment following the
change in NICE guidance
Fiona E Matthews, Graciela Muniz-Terrera, Ian McKeith, Carol
Brayne
International
Journal of Geriatric Psychiatry. Volume 25 Issue 7, Pages 719 - 724
GRATIS 5
- A Phase 3,
Double-Blind, Randomized, Placebo-Controlled Study of Armodafinil for Excessive
Sleepiness Associated With Jet Lag Disorder
Russell P. Rosenberg, Richard K. Bogan, Jane M. Tiller, Ronghua Yang,
James M. Youakim, Craig Q. Earl, and Thomas Roth
3 - Dapoxetine
for premature ejaculation
Chris G McMahon
Expert
Opinion on Pharmacotherapy. July 2010, Vol. 11, No. 10, Pages 1741-1752
3 - Memantine
ER, a once-daily formulation for the treatment of Alzheimer's disease
Nazem Bassil, Papan Thaipisuttikul & George T Grossberg
Expert
Opinion on Pharmacotherapy. July 2010, Vol. 11, No. 10, Pages 1765-1771
3! - Risk of Cerebrovascular Adverse Events in Older Adults Using
Antipsychotic Agents: A Propensity-Matched Retrospective Cohort Study
Sandhya Mehta, Michael L. Johnson, Hua Chen,
and Rajender R. Aparasu
J Clin Psychiatry 2010;71(6):689–698
3 - Modafinil Treatment for Fatigue in HIV/AIDS: A Randomized
Placebo-Controlled Study
Judith G. Rabkin, Martin C. McElhiney, Richard
Rabkin, and Patrick J. McGrath
J Clin Psychiatry 2010;71(6):707–715
5 - A Comparison of the Efficacy of Medications for Adult
Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes
Stephen V. Faraone, and Stephen J. Glatt
J Clin Psychiatry 2010;71(6):754–763
3! - Influence of Anesthetic Drugs and Concurrent Psychiatric Medication on
Seizure Adequacy During Electroconvulsive Therapy
Bogata D. Bundy, Walter Hewer, Franz-Josef
Andres, Peter Gass, and Alexander Sartorius
J Clin Psychiatry 2010;71(6):775–777
3 - Exposure-Response
Analyses of the Effects of Pregabalin in Patients With Fibromyalgia Using Daily
Pain Scores and Patient Global Impression of Change
Wonkyung
Byon, Daniele Ouellet, Marci Chew, Kaori Ito, Paula Burger, Lynne Pauer,
Bernhardt Zeiher, and Brian Corrigan
J Clin Pharmacol 2010 50: 803
-815
3 - Nervous
system adverse responses to topiramate in the treatment of neuropsychiatric
disorders
Jurjen J Luykx & Johannes A Carpay
Expert
Opinion on Drug Safety. July 2010, Vol. 9, No. 4, Pages 623-631
3 - Safety and tolerability of duloxetine in
the acute management of diabetic peripheral neuropathic pain: analysis of
pooled data from three placebo-controlled clinical trials
Jerry A Hall, Fujun Wang, Tina M Myers
Oakes, Barbara G Utterback, Antonio Crucitti, Nayan Acharya
Expert
Opinion on Drug Safety, Vol. 9, No. 4, Pages 525-537
3 - Are the colors and shapes of current psychotropics designed to maximize
the placebo response?
Arif Khan, Eswara Prasad Bomminayuni,
Amritha Bhat, James Faucett and Walter A. Brown
Psychopharmacology. Volume
211, Number 1 / July, 2010: 113-122
GRATIS (previo registro) 3 - Ácidos omega-3 en psicogeriatría: implicaciones en depresión y demencia
J. Caballer-García, L. Jiménez-Treviño
PSICOGERIATRÍA 2010; 2 (2):
83-92
GRATIS (previo
registro) 3 - Perspectivas sobre la hipótesis
de la cascada del amiloide en la enfermedad de Alzheimer
A.M.
Simón, D. Frechilla, J. del Río
3 - Behavioral
Effects of d-Amphetamine in Humans: Influence of Subclinical Levels of
Inattention and Hyperactivity
Rajkumar J.
Sevak, William
W. Stoops, and Craig
R. Rush
The
American Journal of Drug and Alcohol Abuse. July 2010, Vol. 36, No. 4, Pages 220-227
3! - Maintenance of Effect of Duloxetine in
Patients with Chronic Low Back Pain: A 41-week Uncontrolled, Dose-blinded Study
Vladimir Skljarevski, Shuyu Zhang, Amy S. Chappell, Daniel J. Walker, Isabelle Murray, and Miroslav Backonja
Pain Medicine. Volume 11 Issue 5, Pages 648 - 657
4 - Pain
Response Profile of Patients With Fibromyalgia Treated With Duloxetine
Bradley, Laurence A; Wohlreich, Madelaine M; Wang,
Fujun; Gaynor, Paula J; Robinson, Michael J; D'Souza, Deborah N; Mease, Philip
J
Clinical
Journal of Pain: July/August 2010 - Volume 26 - Issue 6 - pp 498-504
3 - Subjective and Objective Effects of the Novel Triple
Reuptake Inhibitor Tesofensine in Recreational Stimulant Users
K A Schoedel, D Meier, B Chakraborty, P
M Manniche and E M Sellers
Clinical
Pharmacology & Therapeutics (2010) 88 1, 69–78
5 - Twenty-four-week
treatment with extended release methylphenidate improves emotional symptoms in
adult ADHD
Michael Rösler, Wolfgang Retz,
Roland Fischer,
Claudia Ose,
Barbara Alm,
Jürgen Deckert,
Alexandra Philipsen, Sabine Herpertz
& Richard Ammer
World Journal of
Biological Psychiatry. August 2010, Vol. 11, No. 5, Pages 709-718
3 - Persistence with cholinesterase
inhibitor therapy in a population-based cohort of patients with Alzheimer's
disease
Joseph E. Amuah, David B. Hogan, Misha
Eliasziw, Alison Supina, Patricia Beck, Winanne Downey, Colleen J. Maxwell
Pharmacoepidemiology
and Drug Safety. Volume 19 Issue 7, Pages 670 - 679
3 - Factors associated with persistence of
cholinesterase inhibitor treatments in the elderly
Antoine Pariente, Marion Pinet, Yola
Moride, Yvon Merlière, Nicholas Moore, Annie Fourrier-Réglat
Pharmacoepidemiology
and Drug Safety. Volume 19 Issue 7, Pages 680 - 686
3 - Trials
Assessing Parmacotherapeutic Management of Aggression in Psychiatric Patients:
Comparability with Clinical Practice
L.
E. Goedhard, J. J. Stolker, H. L. I. Nijman, T. C.
G. Egberts, E. R. Heerdink
3 - What are the cognitive effects of stimulant
medications? Emphasis on adults with attention-deficit/hyperactivity disorder
(ADHD)
Claire
Advokat
Neuroscience & Biobehavioral Reviews. Volume 34, Issue 8, July
2010, Pages 1256-1266
3 - Duloxetine
reduces morphine requirements after knee replacement surgery
British Journal of Anaesthesia, published online on
June 23, 2010
3 - S3 guidelines on dementia. Symptomatic therapy of dementia
L. Frölich
5 - Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist,
SB-742457, in Alzheimer's Disease
G. Maher-Edwards, M. Zvartau-Hind, A.J.
Hunter, M. Gold, G. Hopton, G. Jacobs, M. Davy, P. Williams
Current Alzheimer Research
2010. Volume 7 Issue 5: 374-385
3 - Established Donepezil Treatment Modulates Regional Brain Activation in
Early Alzheimer's Disease
W.J. McGeown, M.F. Shanks, K.E. Forbes-McKay,
G.D. Waiter, I. Elrick, M.G. Venneri, A. Venneri
Current Alzheimer Research
2010. Volume 7 Issue 5: 415-427
3 - The Serum Protein and Lipid Oxidation Marker Levels in Alzheimer's
Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs
Therapy
F. Sinem, K. Dildar, E. Gokhan, B. Melda, Y.
Orhan, M. Filiz
Current Alzheimer Research
2010. Volume 7 Issue 5: 463-469
| Regresar a RESÚMENES JUNIO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |